Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: A retrospective analysis of the Canadian ENHANCE cohort

Keyphrases

• Retrospective Analysis 100%
• Low Mortality 100%
• Severe Sepsis 100%
• Drotrecogin Alfa 100%
• Time-to-treatment 28%
• Platelet Count 28%
• Logistic Regression 14%
• All Ages 14%
• Improved Survival 14%
• Patient's Will 14%
• Outcome Prediction 14%
• Sepsis 14%
• Creatinine 14%
• Early Use 14%
• Combined Modality Therapy 14%
• Clinical Status 14%
• Infected Patients 14%
• Treatment Change 14%
• Early Markers 14%
• Organ Dysfunction 14%
• Dynamic Change 14%
• 28-day Mortality 14%
• Aggressive Interventions 14%
• Clinical Predictors 14%
• Early Change 14%
• Dynamic Setting 14%
• First Day 14%
• Serum Creatinine 14%
• Independent Predictors of Mortality 14%

Nursing and Health Professions

• Sepsis 100%
• Drotrecogin 100%
• Platelet Count 25%
• Time to Treatment 25%
• Logistic Regression Analysis 12%
• Infusion 12%
• Creatinine Blood Level 12%
• Creatinine 12%

Immunology and Microbiology

• Platelet Count 100%
• Creatinine Blood Level 50%